Literature DB >> 14960582

Wnt activates the Tak1/Nemo-like kinase pathway.

Linda Smit1, Annette Baas, Jeroen Kuipers, Hendrik Korswagen, Marc van de Wetering, Hans Clevers.   

Abstract

Genetic studies on endoderm-mesoderm specification in Caenorhabditis elegans have demonstrated a role for several Wnt cascade components as well as for a MAPK-like pathway in this process. The latter pathway includes the MAPK kinase kinase-like MOM-4/Tak1, its adaptor TAP-1/Tab1, and the MAPK-like LIT-1/Nemo-like kinase. A model has been proposed in which the Tak1 kinase cascade counteracts the Wnt cascade at the level of beta-catenin/TCF phosphorylation. In this model, the signal that activates the Tak1 kinase cascade is unknown. As an alternative explanation of these genetic data, we have explored whether Tak1 is directly activated by Wnt. We find that Wnt1 stimulation results in autophosphorylation and activation of MOM-4/Tak1 in a TAP-1/Tab1-dependent fashion. Wnt1-induced Tak1 stimulation activates Nemo-like kinase, resulting in the phosphorylation of TCF. Our results combined with the genetic data from C. elegans imply a mechanism whereby Wnt directly activates the MOM-4/Tak1 kinase signaling pathway. Thus, Wnt signal transduction through the canonical pathway activates beta-catenin/TCF, whereas Wnt signal transduction through the Tak1 pathway phosphorylates and inhibits TCF, which might function as a feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960582     DOI: 10.1074/jbc.M307801200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  PR72, a novel regulator of Wnt signaling required for Naked cuticle function.

Authors:  Menno P Creyghton; Giulietta Roël; Pieter J A Eichhorn; E Marielle Hijmans; Irma Maurer; Olivier Destrée; René Bernards
Journal:  Genes Dev       Date:  2005-02-01       Impact factor: 11.361

2.  Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3.

Authors:  Lisa M Galli; Tiffany Barnes; Tina Cheng; Lisa Acosta; Adolph Anglade; Karl Willert; Roel Nusse; Laura W Burrus
Journal:  Dev Dyn       Date:  2006-03       Impact factor: 3.780

3.  Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.

Authors:  Hiroki Hikasa; Sergei Y Sokol
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

4.  TGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.

Authors:  Sung Il Kim; So-Young Lee; Zhibo Wang; Yan Ding; Nadeem Haque; Jiwang Zhang; Jing Zhou; Mary E Choi
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

5.  Mixed lineage kinase 3 modulates β-catenin signaling in cancer cells.

Authors:  Ramesh P Thylur; Subramanian Senthivinayagam; Edward M Campbell; Velusamy Rangasamy; Nithyananda Thorenoor; Gautam Sondarva; Suneet Mehrotra; Prajna Mishra; Erin Zook; Phong T Le; Ajay Rana; Basabi Rana
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 6.  Wnt signaling through T-cell factor phosphorylation.

Authors:  Sergei Y Sokol
Journal:  Cell Res       Date:  2011-05-24       Impact factor: 25.617

7.  β-Catenin-related protein WRM-1 is a multifunctional regulatory subunit of the LIT-1 MAPK complex.

Authors:  Xiao-Dong Yang; Tejas R Karhadkar; Jessica Medina; Scott M Robertson; Rueyling Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

Review 8.  The way Wnt works: components and mechanism.

Authors:  Kenyi Saito-Diaz; Tony W Chen; Xiaoxi Wang; Curtis A Thorne; Heather A Wallace; Andrea Page-McCaw; Ethan Lee
Journal:  Growth Factors       Date:  2012-12-21       Impact factor: 2.511

9.  The N- or C-terminal domains of DSH-2 can activate the C. elegans Wnt/beta-catenin asymmetry pathway.

Authors:  Ryan S King; Stephanie L Maiden; Nancy C Hawkins; Ambrose R Kidd; Judith Kimble; Jeff Hardin; Timothy D Walston
Journal:  Dev Biol       Date:  2009-01-23       Impact factor: 3.582

10.  Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.

Authors:  Katayoon H Emami; Lisha G Brown; Tiffany E M Pitts; Xizhang Sun; Robert L Vessella; Eva Corey
Journal:  Prostate       Date:  2009-10-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.